Corning Acquires Optical Biosensor Patent Rights from Oerlikon
Corning Incorporated announced that it has acquired from Oerlikon the worldwide exclusive rights to U.S. Patent 5,738,825 and its foreign counterparts, which cover microplate-based optical biosensors. Corning had previously acquired a joint ownership right in the patent from Artificial Sensing Instruments, AG of Switzerland as part of a broader technology exchange. By acquiring these exclusive rights in the patent from Oerlikon, Corning will not only have the right to continue to practice the technology disclosed, but will now also have the full right to enforce the patent.
"We are pleased to expand our portfolio of enforceable patents as we continue to invest in this exciting commercial opportunity," stated Dr. Jeff Mooney, commercial technology director for Corning Life Sciences.
Other news from the department business & finance
These products might interest you
Octet R2 / Octet R4 / Octet R8 by Sartorius
Full power on 2, 4 or 8 channels: Label-free and GxP-compliant analysis of molecular interactions
Innovative label-free real-time protein quantification, binding kinetics and rapid screenings
Octet RH16 and RH96 by Sartorius
Efficient protein analysis for process optimisation and manufacturing control in high-throughput
Label-free protein quantification and characterization of protein-protein interactions
Octet SF3 by Sartorius
Surface Plasmon Resonance (SPR) using Single Dynamic Injections for Kinetics and Affinities
Curvature is Key - Adding a ‘Third Dimension’ to the Binding Curve
Get the analytics and lab tech industry in your inbox
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
